|
Market Closed -
Nasdaq
00:00:00 21/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 22.88 USD | +3.95% |
|
+2.55% | -67.10% |
| 09-30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 09-21 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| Market Cap | 1.63B 1.45B 1.35B 1.22B 2.29B 155B 2.33B 16.15B 6.34B 80.89B 6.12B 5.99B 258B | P/E 2026 * |
-14.2x | P/E 2027 * | -10.5x |
|---|---|---|---|---|---|
| Enterprise Value | 664M 591M 548M 497M 933M 62.94B 949M 6.58B 2.58B 32.94B 2.49B 2.44B 105B | EV / Sales 2026 * |
15.9x | EV / Sales 2027 * | 23,594x |
| Free-Float |
94.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GPCR | Delayed | |
CBOE
| GPCR | Real-time |
Last Transcript: Structure Therapeutics Inc.
| 1 day | +3.95% | ||
| 1 week | +2.55% | ||
| Current month | -26.83% | ||
| 1 month | -34.63% | ||
| 3 months | -51.30% | ||
| 6 months | -52.55% | ||
| Current year | -67.10% |
| 1 week | 20.72 |  | 23.83 |
| 1 month | 20.72 | | 37.74 |
| Current year | 20.72 | | 94.77 |
| 1 year | 20.72 | | 94.9 |
| 3 years | 13.22 | | 94.9 |
| 5 years | 13.22 | | 94.9 |
| 10 years | 13.22 | | 94.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jun Yoon
DFI | Director of Finance/CFO | 48 | 01/05/2022 |
Raymond Stevens
CEO | Chief Executive Officer | 62 | 01/05/2019 |
Matthew Lang
COO | Chief Operating Officer | 49 | 15/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Stevens
BRD | Director/Board Member | 62 | 01/02/2019 |
Daniel Welch
CHM | Chairman | 68 | 19/01/2022 |
Sharon Tetlow
BRD | Director/Board Member | 66 | 29/03/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/09/26 | Conversion | Chief Technology Officer | -20,040 | 0.0143% | ||
| 01/09/26 | Exercice | Chief Technology Officer | 65,329 | 0.0467% | ||
| 18/08/26 | Exercice | Chief Technology Officer | 43,329 | 0.0310% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.95% | +2.55% | -17.90% | -66.11% | 1.57B | |
| +0.79% | -6.16% | +49.32% | +74.50% | 65.83B | |
| +1.92% | +10.35% | +13.02% | +87.74% | 51.87B | |
| +6.91% | +8.57% | +6.88% | +72.12% | 51.2B | |
| +0.74% | +2.75% | +26.31% | +45.29% | 43.76B | |
| +3.87% | +10.15% | +20.69% | +132.73% | 42.09B | |
| +7.91% | +4.30% | +263.91% | +602.72% | 39.04B | |
| -0.40% | +9.85% | +17.04% | +59.17% | 34B | |
| -0.26% | +0.36% | +38.59% | +8.17% | 25.2B | |
| +2.36% | +5.34% | +30.98% | +26.07% | 22.8B | |
| Average | +2.78% | +0.70% | +44.88% | +104.24% | 37.74B | |
| Weighted average by Cap. | +2.78% | +1.96% | +49.90% | +124.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 41.67M 37.09M 34.37M 31.15M 58.54M 3.95B 59.52M 412M 162M 2.07B 156M 153M 6.59B | 45.45K 40.46K 37.49K 33.98K 63.85K 4.31M 64.92K 450K 177K 2.25M 170K 167K 7.19M |
| Net income | -314M -279M -259M -235M -441M -29.73B -448M -3.11B -1.22B -15.56B -1.18B -1.15B -49.63B | -471M -419M -389M -352M -662M -44.62B -673M -4.66B -1.83B -23.35B -1.77B -1.73B -74.49B |
| Net Debt | -967M -861M -798M -723M -1.36B -91.62B -1.38B -9.57B -3.76B -47.95B -3.63B -3.55B -153B | -559M -498M -461M -418M -786M -52.97B -799M -5.54B -2.17B -27.72B -2.1B -2.05B -88.44B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/10/26 | $22.88 | +3.95% | 1,409,082 |
| 19/10/26 | $22.01 | +4.41% | 1,312,855 |
| 16/10/26 | $21.08 | -5.00% | 1,160,791 |
| 15/10/26 | $22.19 | +1.42% | 1,414,161 |
| 14/10/26 | $21.88 | -1.93% | 2,069,294 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GPCR Stock
Select your edition
All financial news and data tailored to specific country editions
